Digital Changing Faces: Digital and supplier hires – April 2026 Leadership changes across digital health, diagnostics, clinical trial technology, and life sciences suppliers continued in April.
R&D Changing Faces: Pharma and biotech, April 2026 April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.
R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
Sales & Marketing Changing Faces: Agency, consultancy, and investor, March 202... March saw a handful of noteworthy hires in the agency, consultancy, and investor spaces.
Digital Changing Faces: Digital and supplier, March 2026 Digital health companies, clinical trial technology providers, and life sciences suppliers continued to invest in senior leadership in March.
R&D Changing Faces: Pharma and biotech, March 2026 A broad mix of senior leadership and scientific and commercial appointments shaped last month’s pharma and biotech hiring activity.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.